We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Acquisition of DG Innovate & Suspension

13 Aug 2021 07:45

RNS Number : 5189I
Path Investments plc
13 August 2021
 

 

13 August 2021

Path Investments plc("Path" or the "Company")

Proposed Acquisition of DG Innovate Limited

and

Suspension of Listing

 

Path Investments plc (TIDM: PATH), is pleased to announce that it has entered into a conditional sale and purchase agreement (the "Agreement") to acquire the entire issued share capital of DG Innovate Ltd ("DG Innovate") (the "Proposed Transaction").

 

Highlights

 

· Conditional agreement to acquire DG Innovate for £32 million to be satisfied by the issue of 5,342,051,305 Path Ordinary Shares of £0.001 each ("Path Shares") at an issue price of 0.6 pence per Path Share.

· DG Innovate is an advanced research and development company focusing on novel electric motor technologies and energy storage solutions.

· The Proposed Transaction is subject to the approval of Path's independent shareholders and waiver of Rule 9 of the Takeover Code by the Takeover Panel.

· The Proposed Transaction constitutes a reverse takeover under the Listing Rules as it will result in a fundamental change in the business of the Company.

· The Company has requested from the FCA the suspension of the Company's listing on the Standard Segment of the Official List, and from trading on the Main Market of the London Stock Exchange from 7.30am today pending the publication of a prospectus and the application by the Company to have its enlarged share capital listed on the Standard Segment of the Official List and admitted to trading on the Main Market.

· Path is providing a secured loan facility to DG Innovate of up to £600,000 and an initial £300,000 has been provided on signing of the Agreement.

 

DG Innovate

 

DG Innovate is a research and development company pioneering sustainable and environmentally considerate improvements to electric mobility and storage, focusing on the use of abundant materials and best engineering and scientific practices. The business was founded in 2009 by Martin Boughtwood, an engineer and inventor with over 40 years' experience. It is intended that Martin will join the board as Chief Technology Officer of the Company on completion of the Proposed Transaction.

 

DG Innovate is currently developing products alongside major manufacturers across the transportation and energy sectors, research institutions and the UK's Ministry of Defence ("MOD") and has filed over 20 patents worldwide in the last five years.

 

DG Innovate's current research and development activities are broadly split into two areas, focusing on novel electric motor technologies and energy storage solutions. Its two main products are:

 

Enhanced Drive Technology (EDT) - ultra high efficiency, lightweight, cost-effective electric motors and electronics; and

 

Enhanced Battery Technology (EBT) -fully-recyclable, sodium-ion batteries utilising abundant materials, and offering comparable or greater energy density to incumbent battery technologies at lower cost and environmental impact.

 

DG Innovate is working with a number of potential customers across the transportation and energy sectors, including the MOD, a global Tier 1 commercial vehicle supplier and a major consumer automotive OEM.

 

To date, DG Innovate has raised funding from private investors, the UK Government, the Welsh Development Agency and through competitive grant awards under the Innovate UK Faraday Challenge. The Proposed Acquisition is intended to provide DG Innovate with a more robust capital structure, access to the public equity markets and an enhanced leadership team as it seeks to move into product commercialisation in the short-to-medium term.

 

Further information on DG Innovate may be found at: https://www.dginnovate.com.

 

Principal Terms of the Proposed Transaction

 

Path has agreed to acquire the total issued share capital of DG Innovate for a consideration of £32 million, to be satisfied by the issue of 5,342,051,305 new Path Shares at an issue price of 0.6 pence per Path Share.

 

Completion of the Proposed Transaction is subject to conditions, including the approval of Path shareholders at a general meeting to be convened in due course and the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority ("FCA") under section 87A of Financial Services and Markets Act 2000 (as amended). Following publication of the prospectus, the Board expects Path's ordinary shares to be readmitted to the Standard Segment of the Official List maintained by the FCA and readmitted to trading on the Main Market of the London Stock Exchange. The Agreement includes a long stop date for the satisfaction of all conditions of 31 October 2021.

 

The Agreement also contains warranties between the parties customary for a transaction of this nature.

 

Temporary Suspension

 

The Proposed Transaction is classified as a reverse takeover in accordance with the FCA's Listing Rules. Accordingly, the Company has requested the suspension of the Company's listing on the Standard Segment of the Official List and from trading on the Main Market of the London Stock Exchange be suspended with effect from 7:30am today pending the publication of a prospectus and the application by the Company to have its enlarged share capital listed on the Standard Segment of the Official List and admitted to trading on the Main Market.

 

The parties intend to proceed as quickly as possible with the Proposed Transaction. However, there can be no certainty that the Proposed Transaction will be successfully completed. If the Proposed Acquisition does not complete for any reason, it is expected that the suspension of the Company's listing will be lifted subject to FCA approval and trading in the Path Shares will recommence.

 

The Company will make further announcements in due course, as appropriate.

 

Commenting, Christopher Theis CEO of Path, said: "We are delighted to have agreed the terms for the acquisition of DG Innovate. DG Innovate is at the forefront of motor drive technology for electric vehicles, with its innovative technology, together with offering, through its sodium-ion battery technology, a potentially cleaner and cheaper alternative to incumbent technologies.

 

"We believe that DG Innovate's technology and IP portfolio, targeted at current market technology's shortcomings, coupled with its strong commercial relationships, high calibre technical staff and near-term commercialisation opportunities make it the ideal target for Path.

 

"We are currently working hard to complete the required prospectus and look forward to making further announcements as matters progress."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

Jack Allardyce

 

 

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

 

 

Grant Thornton UK LLP (Financial Adviser)

Samantha Harrison

Harrison Clarke

Lukas Girzadas

020 7383 5100

 

 

 

ETX Capital (Broker)

020 7392 1400

Tom Curran

Thomas Smith

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SRSEAXPAFFXFEFA
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.